Unicycive Therapeutics (UNCY) Non Operating Interest Expenses (2020 - 2025)
Unicycive Therapeutics' Non Operating Interest Expenses came in at $27,000 for Q4 2025, up 35.0% from $20,000 a year earlier and up 80.0% from the prior quarter.
Unicycive Therapeutics (UNCY) Non Operating Interest Expenses (2020 - 2025) Analysis & Trends
For FY2025, Unicycive Therapeutics' Non Operating Interest Expenses was $71,000, unchanged from FY2024.
- Non Operating Interest Expenses carries a five-year compound annual growth rate of -21.9% (FY2020 to FY2025).
- Going back by year, Non Operating Interest Expenses was $71,000 in FY2024 (-13.4%), $82,000 in FY2023, $6,000 in FY2022 (-99.0%) and $628,000 in FY2021 (+157.4%).
- The Q4 2025 figure represents the highest quarterly Non Operating Interest Expenses since Q2 2023.
- Year-over-year, Non Operating Interest Expenses increased in three of the last eight quarters, with an average decline of 0.4%.
- The fastest year-over-year change in Non Operating Interest Expenses over five years came in Q4 2023 (growth of 533.3%), and the weakest in Q3 2022 (a decline of 94.5%).
- Business Quant data shows UNCY's Non Operating Interest Expenses at $15,000 (Q3 2025), $13,000 (Q2 2025) and $15,000 (Q1 2025) in the three quarters before Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,147.74 Bn | 1,116.33 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 636.22 Bn | 556.08 Bn | 17.30 Bn | 217.00 Mn |
| 3 | AbbVie | 502.73 Bn | 475.84 Bn | 12.70 Bn | - |
| 4 | Merck | 357.93 Bn | 312.30 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 301.67 Bn | 265.66 Bn | 11.24 Bn | 462.00 Mn |
| 6 | Astrazeneca | 264.02 Bn | 237.70 Bn | 12.86 Bn | 435.00 Mn |
| 7 | Amgen | 239.31 Bn | 194.70 Bn | 7.24 Bn | 673.00 Mn |
| 8 | Gilead Sciences | 194.97 Bn | 169.17 Bn | 6.22 Bn | 247.00 Mn |
| 9 | Pfizer | 171.63 Bn | 118.27 Bn | 10.94 Bn | - |
| 10 | Unicycive Therapeutics | 103.50 Mn | -96.48 Mn | - | - |
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 27,000.00 |
| Sep 30, 2025 | 15,000.00 |
| Jun 30, 2025 | 13,000.00 |
| Mar 31, 2025 | 15,000.00 |
| Dec 31, 2024 | 20,000.00 |
| Sep 30, 2024 | 15,000.00 |
| Jun 30, 2024 | 16,000.00 |
| Mar 31, 2024 | 20,000.00 |
| Dec 31, 2023 | 19,000.00 |
| Sep 30, 2023 | 18,000.00 |
| Jun 30, 2023 | 32,000.00 |
| Mar 31, 2023 | 12,000.00 |
| Dec 31, 2022 | 3,000.00 |
| Sep 30, 2022 | 3,000.00 |
| Sep 30, 2021 | 55,000.00 |
| Jun 30, 2021 | 321,000.00 |
| Mar 31, 2021 | 252,000.00 |
| Dec 31, 2020 | 163,000.00 |
| Sep 30, 2020 | 76,000.00 |
| Jun 30, 2020 | 2,000.00 |
Unicycive Therapeutics Non Operating Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=UNCY&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-interest-expenses", "ticker": "UNCY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=UNCY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();